Jitesh Dhingra We frequently observe FDG uptake in the myocardium while performing whole body oncologic PET/CT scans. In this review we will demonstrate a spectrum of FDG findings in myocardium to allow a better interpretation of FDG PET images and reduce clinical...
Based on the above, the patient is getting treatment for: NET Non-Hodgkin's Lymphoma Prostate Cancer Thyroid Cancer
A 65 year female w/ memory loss, cognitive impairment & MMSE score of 21. After a thorough workup, dementia is suspected. She undergoes this scan. Based on the scan, the patient: 1. Most likely has Fronto-temporal dementia. 2. Is unlikely to have Alzheimer’s...
What is Nuclear Medicine & Molecular Imaging?
Molecular imaging is a type of medical imaging that provides detailed pictures of what is happening inside the body at the molecular and cellular level.
About Nuclear Medicine & Molecular Imaging:
Nuclear Medicine is branch of medicine that uses the radioactivity for diagnosis and therapy. It started in the mid-1920s when German scientists experimented with radionuclides on rats.
Diagnostic Nuclear Medicine (Radionuclide Imaging, Nuclear Scintigraphy):
Tracers (pharmaceuticals labeled with radiation emitting isotopes or radionuclides) are administered to patients (either intravenous, orally, inhalation, subcutaneously/subdermally) and the radiation emitted is detected by scintillation cameras (gamma cameras or PET cameras) and images are produced from this, depicting the distribution of the tracer within the body.
Therapeutic Nuclear Medicine:
Radiopharmaceuticals are administered (usually intravenously) to treat disease with curative or palliative intent. They act by killing abnormal cells within the body by high but localized radiation exposure (akin to targeted internal radiation).
PET/CT, a hybrid imaging technique, combines functional/physiologic imaging with the more traditional anatomic/structural imaging. By providing the best of both worlds, it has played a pivotal role in ushering in the new era of Molecular Imaging, to go hand in hand with Molecular Medicine in the 21st century.
The Indo-American Society of Nuclear Medicine (IASNM) was conceived in 1979 and incorporated as a non-profit tax-exempt organization in the State of Texas in 1984. The membership of the Society primarily consists of physicians, scientists and technologists in nuclear medicine, although interested professionals in other disciplines also can be members of the Society. The major objective of this Society is to advance the profession of nuclear medicine through exchange of ideas and knowledge among its members, and also to help promote the state-of-the-art nuclear medicine in the developing countries, namely, India.